Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis

Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache

Run by Beijing Tiantan Hospital · NCT07347054 · Data updated 2026-11-12

This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment1036 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2026
Study endsJune 1, 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07347054 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45 or older with radiographic shoulder osteoarthritis (Kellgren-Lawrence grade 1–4), at least one myofascial trigger point, disease >3 months, and NRS pain ≥3 despite prior conservative treatment are the intended participants.

Probably not a fit

Patients with corticosteroid allergy, recent intra-articular injections, long-term systemic steroid use, significant comorbidities (severe organ dysfunction, inflammatory rheumatic disease), substance abuse, or other exclusion criteria are unlikely to benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, controlled, blinded-outcome, non-inferiority trial comparing two injection approaches for shoulder osteoarthritis: glucocorticoid injection at myofascial trigger points (MTrPs) versus intra-articular (joint cavity) glucocorticoid injection. Eligible patients are randomized into one of the two treatment groups and receive the assigned injection, with standardized procedures and follow-up visits. Patients will be followed for two years with repeated measures of pain and function (for example, NRS and common osteoarthritis function scales) to compare long-term effects. The design focuses on whether MTrP injections can provide similar durable symptom relief while being easier to perform.

Why it matters

Potential benefit: If successful, patients could get similar long-term pain relief and improved shoulder function with a simpler, safer, and easier-to-deliver injection into trigger points instead of direct joint injection.

How similar studies have gone: Previous domestic and international reports have shown that glucocorticoid injections at myofascial trigger points can reduce pain short-term, but long-term data and head-to-head non-inferiority comparisons with intra-articular injections are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of shoulder osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point;
* Disease duration exceeding 3 months;
* Age ≥ 45 years;
* Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment;
* Signed informed consent form.

Exclusion Criteria:

* History of allergy to trial medications such as corticosteroids;
* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;
* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;
* Intra-articular injection within the past 6 months or planned joint replacement surgery;
* Inability to use pain assessment scales;
* Presence of local or systemic infection;
* Pregnant or lactating patients.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.